Gautam Patel - Dec 1, 2021 Form 4/A - Amendment Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Signature
/s/ Gautam Patel
Stock symbol
AMRX
Transactions as of
Dec 1, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/1/2023, 04:15 PM
Date Of Original Report
Dec 1, 2021
Previous filing
May 7, 2021
Next filing
Dec 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Other +3.07M +23.85% 16M Dec 1, 2021 Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 1, 2021, an entity controlled by the reporting person was designated as the trustee of a trust that holds 3,073,298 shares of the Class A Common Stock of the issuer. These shares were not previously reported as being beneficially owned by the reporting person due to a clerical error. The reporting person is filing this amendment to the Form 4 filed on December 20, 2021, to include the shares held by the trust in the number of shares reported as being beneficially owned by the reporting person through trusts which the reporting person may be deemed to control. As a result of the error, all Section 16 reports filed by the reporting person after December 20, 2021 understated the number of shares of the Class A Common stock of the issuer beneficially owned by the reporting person by 3,073,298 shares. All such subsequent reports are hereby updated by this amendment.
F2 By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.